Corrigendum to "Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence" [Pharmacol. Res. 181 (2022), 106259
机构：[1]The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing 100050, China; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.[2]Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial，People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China.[3]The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing 100050, China; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China. Electronic address: wjh@imm.ac.cn.
第一作者机构：[1]The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing 100050, China; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.
推荐引用方式(GB/T 7714)：
Liu Jinyi,Zheng Xiangjin,Li Wan,et al.Corrigendum to "Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence" [Pharmacol. Res. 181 (2022), 106259[J].Pharmacological Research.2024,205:107249.doi:10.1016/j.phrs.2024.107249.
APA：
Liu Jinyi,Zheng Xiangjin,Li Wan,Ren Liwen,Li Sha...&Wang Jinhua.(2024).Corrigendum to "Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence" [Pharmacol. Res. 181 (2022), 106259.Pharmacological Research,205,
MLA：
Liu Jinyi,et al."Corrigendum to "Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence" [Pharmacol. Res. 181 (2022), 106259".Pharmacological Research 205.(2024):107249
医学